This week’s topics include a comparison of once-weekly dulaglutide and once-daily liraglutide in metformin-treated patients with type 2 diabetes and variation in patients’ perceptions of elective PCI in stable CAD.
For two decades, investigators have been studying the association between neighborhood characteristics and cardiovascular disease. A landmark study from 2001 showed that living in a socioeconomically disadvantaged neighborhood was associated with higher incidence of coronary artery disease. Several studies have also shown an association between neighborhood characteristics, most notably the socioeconomic status (SES) and outcomes…
Larry Husten applies Steven Pinker’s ideas about the difficulties of writing to the field of medicine by looking at what makes it difficult for doctors to communicate with their patients.
A correction to the RE-LY trial results, partly brought to light because of litigation, has Harlan Krumholz wondering if this is another example of why we should have open access to clinical trial data.
This week’s topics include medical device safety and effectiveness, familial hypercholesterolemia, and more.
A 47-year-old man presents to the hospital reporting 4 days of chest pain that occurs during treadmill exercise, left-arm and jaw discomfort, and shortness of breath with diaphoresis. His medical history is noteworthy only for orthopedic surgeries and use of testosterone replacement therapy for reportedly low testosterone syndrome. He does not smoke and drinks alcohol only…
This week’s topics include prevalence and incidence trends in diabetes in the U.S., quality of life outcomes with CABG in ischemic left ventricular dysfunction, and more.
Clyde Yancy and Mary Norine Walsh offer their perspectives on the much-discussed PARADIGM-HF trial.
John Ryan discusses his new paper on heterogeneity in pulmonary arterial hypertension clinical practice worldwide. Are you surprised by the lack of standardized care?
Dr. Westby Fisher gets creative with his medical technology.